Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cisplatin and Tretinoin

supplement:

Tretinoin

Research Papers that Mention the Interaction

In vitro growth inhibition and apoptosis effects of cisplatin were differential and inversely associated with those of retinoic acid and especially IFNalpha in two skin SCC lines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  •  2002  |  View Paper
Pretreatment with differentiating agent all-trans retinoic acid counteracts cisplatin resistance specifically of the slowly dividing compartment indicating effect on CD133+/CXCR4+ cells.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  •  2015  |  View Paper
The combinatorial treatment of ATRA acid and cisplatin reduced protein kinase B (AKT) (Thr308) phosphorylation, and promoted apoptosis of HCC cells more significantly than treatment with cisplatin alone.
Journal of hepatology  •  2013  |  View Paper
Furthermore, ATRA treatment augmented the chemosensitising effects of cisplatin.
In conclusion, ATRA may be potentially valuable in treatment of HNSC CSC, especially in combination with cisplatin.
European journal of cancer  •  2012  |  View Paper
ConclusionThese results suggest that retinoids not only exhibit antimetastatic effect, but also enhance the antitumor activity of cisplatin in vivo.
Pretreatment with retinoids increased the sensitivity to CDDP but not to 5-FU in in-vitro.
Cancer Chemotherapy and Pharmacology  •  2008  |  View Paper
In contrast, the association of the two retinoids together with cisplatin did not produce any benefit and resulted in increased toxicity.
In the same tumour model, 4-HPR and RA separately increased cisplatin activity, even though for RA the increase was not statistically significant.
European journal of cancer  •  2000  |  View Paper
CONCLUSIONS AT A si gnificantly enhanced the antitumor effect of cis platin in cervical cancer cells, the mechanism of which might be attributed to its effect of inducing the differentiation of cancer stem-like cells.
Annals of clinical and laboratory science  •  2021  |  View Paper
Furthermore, there was an indication that the combination of ATRA with 5FU and CDDP caused an increase in cell cycle arrest in G2/M and G0/G1.
We conclude that low concentration of ATRA enhances the cytotoxicity of CDDP and 5FU by facilitating apoptosis and cell cycle arrest in gastrointestinal CSCs and provide a rational basis for the design of novel, well-tolerated CDDP- and 5FU-based chemotherapy in human gastrointestinal carcinoma.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2015  |  View Paper
Strong antagonisms were also obtained with ATRA and fotemustine or cisplatin in both cell lines.
British Journal of Ophthalmology  •  2012  |  View Paper
When ATRA was used in combination with cisplatin , the resulting synergistic effects were robust and significant.
European Archives of Oto-Rhino-Laryngology  •  2012  |  View Paper
Show More